EYPT

#1999
EyePoint, Inc. - Common Stock
13.5 8 USD
+0.59%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
13.58
13.58
1年のレンジ
0.12
19.01
1日の変化
+0.59%
月次変化
+4.38%
6か月変化
-7.37%
1年の変化
+13.17%
以前の終値
13.5 0
Open
13.5 8
安値
13.5 8
High
13.5 8
ボリューム
145
チャート全体を表示 Full chart

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 1.14 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-5.76
売上高対価格比率
0.04

EyePoint, Inc. - Common Stock

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

ニュース